Please wait while the formulary information is being retrieved.
Drug overview for LOTEPREDNOL ETABONATE (loteprednol etabonate):
Generic name: LOTEPREDNOL ETABONATE (LOE-te-PRED-nol)
Drug class: Ophthalmic Steroids
Therapeutic class: Ophthalmic Agents
Loteprednol etabonate is a synthetic nonfluorinated corticosteroid.
No enhanced Uses information available for this drug.
Generic name: LOTEPREDNOL ETABONATE (LOE-te-PRED-nol)
Drug class: Ophthalmic Steroids
Therapeutic class: Ophthalmic Agents
Loteprednol etabonate is a synthetic nonfluorinated corticosteroid.
No enhanced Uses information available for this drug.
DRUG IMAGES
No Image Available
The following indications for LOTEPREDNOL ETABONATE (loteprednol etabonate) have been approved by the FDA:
Indications:
Allergic conjunctivitis
Herpes zoster keratitis
Iridocyclitis
Iritis
Ocular inflammation
Ocular rosacea
Post-op ocular inflammation
Postoperative ocular pain
Punctate keratitis
Professional Synonyms:
Acute iritis
Allergy eye itch
Atopic conjunctivitis
Inflammatory cells on the corneal endothelium
Itchy eyes due to allergies
Keratic precipitates
Keratitis punctata
Ocular itching due to allergies
Ophthalmic inflammation
Post-op ocular pain
Postoperative eye pain
Postoperative ocular inflammation
Postoperative ophthalmic inflammation
Indications:
Allergic conjunctivitis
Herpes zoster keratitis
Iridocyclitis
Iritis
Ocular inflammation
Ocular rosacea
Post-op ocular inflammation
Postoperative ocular pain
Punctate keratitis
Professional Synonyms:
Acute iritis
Allergy eye itch
Atopic conjunctivitis
Inflammatory cells on the corneal endothelium
Itchy eyes due to allergies
Keratic precipitates
Keratitis punctata
Ocular itching due to allergies
Ophthalmic inflammation
Post-op ocular pain
Postoperative eye pain
Postoperative ocular inflammation
Postoperative ophthalmic inflammation
The following dosing information is available for LOTEPREDNOL ETABONATE (loteprednol etabonate):
Safety and efficacy of ophthalmic suspensions containing loteprednol etabonate alone or in fixed combination with tobramycin have not been established in children younger than 18 years of age.
Loteprednol etabonate alone or in fixed combination with tobramycin is applied topically to the eye as an ophthalmic suspension. The suspension should be shaken vigorously prior to use. Care should be taken to avoid contamination of the container.
No dosing information available.
| DRUG LABEL | DOSING TYPE | DOSING INSTRUCTIONS |
|---|---|---|
| LOTEPREDNOL ETABONATE 0.5% DRP | Maintenance | Adults instill 1 drop into affected eye(s) by ophthalmic route 4 times per day |
The following drug interaction information is available for LOTEPREDNOL ETABONATE (loteprednol etabonate):
There are 0 contraindications.
There are 0 severe interactions.
There are 0 moderate interactions.
The following contraindication information is available for LOTEPREDNOL ETABONATE (loteprednol etabonate):
Drug contraindication overview.
No enhanced Contraindications information available for this drug.
No enhanced Contraindications information available for this drug.
There are 4 contraindications.
Absolute contraindication.
| Contraindication List |
|---|
| Fungal infection of eye |
| Herpes simplex dendritic keratitis |
| Tuberculosis of the eye |
| Vaccinia virus keratitis |
There are 2 severe contraindications.
Adequate patient monitoring is recommended for safer drug use.
| Severe List |
|---|
| Glaucoma |
| Ocular hypertension |
There are 0 moderate contraindications.
The following adverse reaction information is available for LOTEPREDNOL ETABONATE (loteprednol etabonate):
Adverse reaction overview.
No enhanced Common Adverse Effects information available for this drug.
No enhanced Common Adverse Effects information available for this drug.
There are 12 severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
|
Chemosis |
Keratoconjunctivitis Uveitis |
| Rare/Very Rare |
|---|
|
Bacterial eye infection Cataracts Fungal infection of eye Glaucoma Globe perforation Impaired wound healing Ocular infection Posterior capsule opacification Viral ocular infection |
There are 20 less severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
|
Anterior chamber inflammation Blurred vision Conjunctival hyperemia Corneal edema Dry eye Eye tearing Headache disorder Ocular itching Ocular pain Ocular redness Pharyngitis Photophobia Rhinitis Visual changes |
Conjunctivitis Eyelid erythema Ocular discharge Ocular hypertension Ocular irritation |
| Rare/Very Rare |
|---|
|
Foreign body sensation of eye |
The following precautions are available for LOTEPREDNOL ETABONATE (loteprednol etabonate):
No enhanced Pediatric Use information available for this drug.
Contraindicated
Severe Precaution
Management or Monitoring Precaution
Contraindicated
| None |
Severe Precaution
| None |
Management or Monitoring Precaution
| None |
No enhanced Pregnancy information available for this drug.
No enhanced Lactation information available for this drug.
No enhanced Geriatric Use information available for this drug.
The following prioritized warning is available for LOTEPREDNOL ETABONATE (loteprednol etabonate):
No warning message for this drug.
No warning message for this drug.
The following icd codes are available for LOTEPREDNOL ETABONATE (loteprednol etabonate)'s list of indications:
| Allergic conjunctivitis | |
| H10.1 | Acute atopic conjunctivitis |
| H10.10 | Acute atopic conjunctivitis, unspecified eye |
| H10.11 | Acute atopic conjunctivitis, right eye |
| H10.12 | Acute atopic conjunctivitis, left eye |
| H10.13 | Acute atopic conjunctivitis, bilateral |
| H10.44 | Vernal conjunctivitis |
| H10.45 | Other chronic allergic conjunctivitis |
| H16.26 | Vernal keratoconjunctivitis, with limbar and corneal involvement |
| H16.261 | Vernal keratoconjunctivitis, with limbar and corneal involvement, right eye |
| H16.262 | Vernal keratoconjunctivitis, with limbar and corneal involvement, left eye |
| H16.263 | Vernal keratoconjunctivitis, with limbar and corneal involvement, bilateral |
| H16.269 | Vernal keratoconjunctivitis, with limbar and corneal involvement, unspecified eye |
| Herpes zoster keratitis | |
| B02.33 | Zoster keratitis |
| Iridocyclitis | |
| H20 | Iridocyclitis |
| H20.0 | Acute and subacute iridocyclitis |
| H20.00 | Unspecified acute and subacute iridocyclitis |
| H20.01 | Primary iridocyclitis |
| H20.011 | Primary iridocyclitis, right eye |
| H20.012 | Primary iridocyclitis, left eye |
| H20.013 | Primary iridocyclitis, bilateral |
| H20.019 | Primary iridocyclitis, unspecified eye |
| H20.02 | Recurrent acute iridocyclitis |
| H20.021 | Recurrent acute iridocyclitis, right eye |
| H20.022 | Recurrent acute iridocyclitis, left eye |
| H20.023 | Recurrent acute iridocyclitis, bilateral |
| H20.029 | Recurrent acute iridocyclitis, unspecified eye |
| H20.03 | Secondary infectious iridocyclitis |
| H20.031 | Secondary infectious iridocyclitis, right eye |
| H20.032 | Secondary infectious iridocyclitis, left eye |
| H20.033 | Secondary infectious iridocyclitis, bilateral |
| H20.039 | Secondary infectious iridocyclitis, unspecified eye |
| H20.04 | Secondary noninfectious iridocyclitis |
| H20.041 | Secondary noninfectious iridocyclitis, right eye |
| H20.042 | Secondary noninfectious iridocyclitis, left eye |
| H20.043 | Secondary noninfectious iridocyclitis, bilateral |
| H20.049 | Secondary noninfectious iridocyclitis, unspecified eye |
| H20.1 | Chronic iridocyclitis |
| H20.10 | Chronic iridocyclitis, unspecified eye |
| H20.11 | Chronic iridocyclitis, right eye |
| H20.12 | Chronic iridocyclitis, left eye |
| H20.13 | Chronic iridocyclitis, bilateral |
| H20.2 | Lens-induced iridocyclitis |
| H20.20 | Lens-induced iridocyclitis, unspecified eye |
| H20.21 | Lens-induced iridocyclitis, right eye |
| H20.22 | Lens-induced iridocyclitis, left eye |
| H20.23 | Lens-induced iridocyclitis, bilateral |
| H20.9 | Unspecified iridocyclitis |
| Iritis | |
| A18.54 | Tuberculous iridocyclitis |
| B00.51 | Herpesviral iridocyclitis |
| B02.32 | Zoster iridocyclitis |
| D86.83 | Sarcoid iridocyclitis |
| H20 | Iridocyclitis |
| H20.0 | Acute and subacute iridocyclitis |
| H20.00 | Unspecified acute and subacute iridocyclitis |
| H20.01 | Primary iridocyclitis |
| H20.011 | Primary iridocyclitis, right eye |
| H20.012 | Primary iridocyclitis, left eye |
| H20.013 | Primary iridocyclitis, bilateral |
| H20.019 | Primary iridocyclitis, unspecified eye |
| H20.02 | Recurrent acute iridocyclitis |
| H20.021 | Recurrent acute iridocyclitis, right eye |
| H20.022 | Recurrent acute iridocyclitis, left eye |
| H20.023 | Recurrent acute iridocyclitis, bilateral |
| H20.029 | Recurrent acute iridocyclitis, unspecified eye |
| H20.03 | Secondary infectious iridocyclitis |
| H20.031 | Secondary infectious iridocyclitis, right eye |
| H20.032 | Secondary infectious iridocyclitis, left eye |
| H20.033 | Secondary infectious iridocyclitis, bilateral |
| H20.039 | Secondary infectious iridocyclitis, unspecified eye |
| H20.04 | Secondary noninfectious iridocyclitis |
| H20.041 | Secondary noninfectious iridocyclitis, right eye |
| H20.042 | Secondary noninfectious iridocyclitis, left eye |
| H20.043 | Secondary noninfectious iridocyclitis, bilateral |
| H20.049 | Secondary noninfectious iridocyclitis, unspecified eye |
| H20.1 | Chronic iridocyclitis |
| H20.10 | Chronic iridocyclitis, unspecified eye |
| H20.11 | Chronic iridocyclitis, right eye |
| H20.12 | Chronic iridocyclitis, left eye |
| H20.13 | Chronic iridocyclitis, bilateral |
| H20.2 | Lens-induced iridocyclitis |
| H20.20 | Lens-induced iridocyclitis, unspecified eye |
| H20.21 | Lens-induced iridocyclitis, right eye |
| H20.22 | Lens-induced iridocyclitis, left eye |
| H20.23 | Lens-induced iridocyclitis, bilateral |
| H20.8 | Other iridocyclitis |
| H20.81 | Fuchs' heterochromic cyclitis |
| H20.811 | Fuchs' heterochromic cyclitis, right eye |
| H20.812 | Fuchs' heterochromic cyclitis, left eye |
| H20.813 | Fuchs' heterochromic cyclitis, bilateral |
| H20.819 | Fuchs' heterochromic cyclitis, unspecified eye |
| H20.82 | Vogt-koyanagi syndrome |
| H20.821 | Vogt-koyanagi syndrome, right eye |
| H20.822 | Vogt-koyanagi syndrome, left eye |
| H20.823 | Vogt-koyanagi syndrome, bilateral |
| H20.829 | Vogt-koyanagi syndrome, unspecified eye |
| H20.9 | Unspecified iridocyclitis |
| Ocular inflammation | |
| H57.8 | Other specified disorders of eye and adnexa |
| T86.840 | Corneal transplant rejection |
| T86.8401 | Corneal transplant rejection, right eye |
| T86.8402 | Corneal transplant rejection, left eye |
| T86.8403 | Corneal transplant rejection, bilateral |
| T86.8409 | Corneal transplant rejection, unspecified eye |
| T86.841 | Corneal transplant failure |
| T86.8411 | Corneal transplant failure, right eye |
| T86.8412 | Corneal transplant failure, left eye |
| T86.8413 | Corneal transplant failure, bilateral |
| T86.8419 | Corneal transplant failure, unspecified eye |
| T86.842 | Corneal transplant infection |
| T86.8421 | Corneal transplant infection, right eye |
| T86.8422 | Corneal transplant infection, left eye |
| T86.8423 | Corneal transplant infection, bilateral |
| T86.8429 | Corneal transplant infection, unspecified eye |
| Ocular rosacea | |
| H10.82 | Rosacea conjunctivitis |
| H10.821 | Rosacea conjunctivitis, right eye |
| H10.822 | Rosacea conjunctivitis, left eye |
| H10.823 | Rosacea conjunctivitis, bilateral |
| H10.829 | Rosacea conjunctivitis, unspecified eye |
| Post-op ocular inflammation | |
| H57.8 | Other specified disorders of eye and adnexa |
| Postoperative ocular pain | |
| H57.1 | Ocular pain |
| H57.10 | Ocular pain, unspecified eye |
| H57.11 | Ocular pain, right eye |
| H57.12 | Ocular pain, left eye |
| H57.13 | Ocular pain, bilateral |
| Punctate keratitis | |
| H16.14 | Punctate keratitis |
| H16.141 | Punctate keratitis, right eye |
| H16.142 | Punctate keratitis, left eye |
| H16.143 | Punctate keratitis, bilateral |
| H16.149 | Punctate keratitis, unspecified eye |
Formulary Reference Tool